Note 3 - Stock Purchase Agreement (Tables) - Anaconda Pharma [Member]

12 Months Ended

Jun. 30, 2015

Notes Tables

Schedule of Business Acquisitions, Estimated Purchase Price [Table Text Block

(in millions)
Fair value of Biota common stock issued	$	7.5
Estimated transaction and exit costs		1.0
Cash consideration issued		8.0
Total purchase price	$	16.5

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]

(in millions)
Cash and cash equivalents	$	0.3
Prepaid expenses and other current assets		0.2
Notes payable		(1.0	)
Accounts payable		(0.4	)
Accrued expenses		(0.2	)
Sub-total net fair value of acquired assets and liabilities		(1.1	)
In-process research and development		17.6
Total purchase price	$	16.5

Schedule of Maturities of Long-term Debt [Table Text Block]

Year e nding June 3 0 ,
2016	$	0.2
2017		0.4
2018		0.4
2019		-
2020		-
Total future payments	$	1.0